Teaching medicinal chemistry to meet outcome objectives for pharmacy students

被引:0
作者
Alsharif, NZ [1 ]
Destache, CJ [1 ]
Roche, VF [1 ]
机构
[1] Creighton Univ, Sch Pharm & Allied Hlth Profess, Omaha, NE 68178 USA
关键词
D O I
暂无
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Pharmacy practice demands that pharmacists draw upon competencies and outcomes that enable them to perform the functions that support the delivery of pharmaceutical care. Many:pharmacy schools have established specific outcome objectives for their students based on:published pharmaceutical care functions, practice skills and revised accreditation standards. To meet:these objectives, Students must examine clinical situations rationally and logically, then gather, organize, interpret and analyze data pertinent to the patient in question. Students must be competent to make judgements and therapeutic decisions based on available data, learn from past problem solving successes and failures, and integrate knowledge to : improve the quality of life for;patients. Schools and colleges of pharmacy must ensure that the faculty responsible for instructing in the basic pharmaceutical sciences emphasize not only the core science that underpins their discipline, but also the relevance of that science to the contemporary practice of the profession. The Structurally-Based Therapeutic Evaluation (SBTE) of drugs was introduced in the medicinal chemistry courses at Creighton University in 1995, and reported to interested audiences in 1997. We believe that this instructional approach to medicinal chemistry is one way to help faculty bring practical relevance to the scientific classroom, and encourage:students to-meet practice-based outcomes with an understanding of the scientific rationale behind the practice decisions they will make as professionals.
引用
收藏
页码:34 / 40
页数:7
相关论文
共 14 条
  • [1] Alsharif NZ, 1997, AM J PHARM EDUC, V61, P55
  • [2] *AM COUNC PHARM ED, 1997, ACCR STAND GUID PROF
  • [3] [Anonymous], 1993, AM J PHARM ED, V57, P377
  • [4] *APHA PROF AFF DEP, 1992, ROL PHARM COMPR MED
  • [5] STRUCTURE-ACTIVITY AND STRUCTURE-SIDE-EFFECT RELATIONSHIPS FOR THE QUINOLONE ANTIBACTERIALS
    DOMAGALA, JM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (04) : 685 - 706
  • [6] KNODEL LC, 1997, PHARMACOTHERAPY PATH, P2204
  • [7] MANDELL GL, 1996, PHARMACOL BASIS THER, P1057
  • [8] Martínez LJ, 1998, PHOTOCHEM PHOTOBIOL, V67, P399, DOI 10.1562/0031-8655(1998)067<0399:FASOSA>2.3.CO
  • [9] 2
  • [10] MITSCHER LA, 1995, PRINCIPLES MEDICINAL, P770